Biohaven Pharmaceuticals
CNS Therapeutics

Biohaven Pharmaceuticals is a biopharmaceutical company engaged in the identification and development of clinical stage compounds targeting the glutamatergic system and other neurological pathways. Biohaven has licensed intellectual property from Yale University and several pharmaceutical companies. NYSE: BHVN


University
Yale University
Sector
Life Science
Status
Exited
Initial Investment Stage
Late
Team
View Website